Fatema Hersi

Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy

Raafat El‐Awady, Fatema Hersi, Hala Al-Tunaiji et al. · Cancer Biology & Therapy · 2015 · 52 citations · Full text

Medicine, Genetics, Oncology +13

Sequencing [4 + 1]-Cycloaddition and Aza-Michael Addition Reactions: A Diastereoselective Cascade for the Rapid Access of Pyrido[2′,1′:2,3]/Thiazolo[2′,3′:2,3]imidazo[1,5-<i>a</i>]quinolone Scaffolds as Potential Antibacterial and Anticancer Motifs

Vunnam Srinivasulu, Monther A. Khanfar, Hany A. Omar et al. · The Journal of Organic Chemistry · 2019 · 28 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

Design and synthesis of new energy restriction mimetic agents: Potent anti-tumor activities of hybrid motifs of aminothiazoles and coumarins

Fatema Hersi, Hany A. Omar, Raed A. Al‐Qawasmeh et al. · Scientific Reports · 2020 · 28 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Design, synthesis and biological evaluation of new pyrrolidine carboxamide analogues as potential chemotherapeutic agents for hepatocellular carcinoma

Hany A. Omar, Dana M. Zaher, Vunnam Srinivasulu et al. · European Journal of Medicinal Chemistry · 2017 · 24 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Impact of the ACE2 activator xanthenone on tacrolimus nephrotoxicity: Modulation of uric acid/ERK/p38 MAPK and Nrf2/SOD3/GCLC signaling pathways

Amany A. Azouz, Hany A. Omar, Fatema Hersi et al. · Life Sciences · 2021 · 22 citations

Medicine, Nephrology, Pharmacology +16